Procurement Summary
Country: USA
Summary: High Performance Antigen Diagnostics
Deadline: 17 Jul 2026
Posting Date: 18 Jun 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 143517038
Document Ref. No.: RRPV-HPAD
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
“High Performance Antigen Diagnostics” Request for Information (RFI) Purpose The Rapid Response Partnership Vehicle (RRPV) is issuing this Request for Information (RFI) to better understand the research, development, and product landscape of current and next-generation high performance immunoassay technologies suitable for antigen testing in near-patient settings. While conventional antigen-based immunoassays offer speed, ease of use, and low cost, they remain limited by lower analytical sensitivity and limited multiplexing capability compared to nucleic acid amplification tests (NAATs), limiting their clinical utility, particularly for early infections and syndromic panels.
Notice ID: rrpv-hpad
Department/Ind. Agency: health and human services, department of
Sub-tier: office of assistant secretary for preparedness and response
Office: aspr barda div contracts mgmt & acq
Product Service Code: an13 - health r&d services; health care services; experimental development
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Inactive Dates: aug 01, 2026
Inactive Policy: 15 days after response date
Documents
Tender Notice
Documents.zip